Sponsor pipeline

BeiGene clinical trial pipeline

Get alerts when BeiGene's trials change

13 active trials 3 recruiting 4 Phase 3 20 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
3
Phase 2
3
Phase 3
4
Phase 4
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07169331 A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With… Waldenström's Macroglobulinemia Active, Not Recruiting 2026-08-10
Phase 3
NCT03967977 Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for… Urothelial Carcinoma Active, Not Recruiting 2026-06-22
NCT04379635 Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in… Non Small Cell Lung Cancer Active, Not Recruiting 2026-03-18
NCT03519230 Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive… Ovarian Cancer Active, Not Recruiting 2026-03-16
NCT03336333 A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With… Chronic Lymphocytic Leukemia Active, Not Recruiting 2026-03-09
Phase 2
NCT03736889 Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR… MSI-H/dMMR Solid Tumors Recruiting 2026-07-10
NCT05635708 A Study of Tislelizumab in Combination With Investigational Agents in Participants With… Non-small Cell Lung Cancer Active, Not Recruiting 2026-04-15
NCT05479994 Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic… Leukemia Active, Not Recruiting 2026-03-04
Phase 1/2
NCT05294731 Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton… B-cell Malignancy Recruiting 2026-08-21
NCT05609370 A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab… Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Active, Not Recruiting 2026-07-23
NCT05661955 A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics… Urothelial Carcinoma Active, Not Recruiting 2026-05-11
Phase 1
NCT06257264 A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With… Breast Cancer Active, Not Recruiting 2026-06-18
Not specified
NCT05640102 Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants… Waldenstrom Macroglobulinemia Recruiting 2026-08-07

Disease areas by active trials, top 10 of 20

Bladder Cancer (3) · Chronic Lymphocytic Leukemia (CLL) (3) · Leukemia (3) · Lung Cancer (3) · Non-Small Cell Lung Cancer (NSCLC) (2) · Ovarian Cancer (2) · Breast Cancer (1) · Colorectal Cancer (1) · DLBCL (1) · Endometrial Cancer (1)

Get alerts when BeiGene's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free